肺结节病死亡预测因素
本研究纳入452例有完整肺功能与胸部影像的结节病患者,中位年龄50岁,随访至少8年。随访期间42例死亡,其中38例死于结节病相关呼吸衰竭;结节病总体死亡率5年3.9%、10年9.0%。单因素分析显示黑人种族、胸部X线4期、HRCT纤维化>20%及肺动脉高压与死亡率升高相关,GAP指数和Walsh模型也可预测死亡率。多因素Cox回归仅年龄、HRCT纤维化范围和肺动脉高压为独立预测因素。
要点
- 年龄、HRCT纤维化范围及肺动脉高压是结节病患者死亡的独立预测因素(Cox回归)。
- HRCT纤维化>20%与死亡率升高相关;肺动脉高压经右心导管证实者占6.4%。
- 结节病相关呼吸衰竭死亡38例(8.4%),5年及10年结节病总体死亡率分别为3.9%和9.0%。
- 单因素分析中黑人种族、胸部X线4期、HRCT纤维化>20%、肺动脉高压及GAP/Walsh评分均与死亡率升高相关。
- 存活患者显著年轻于死于结节病的患者。
适用人群与场景
- 452例有完整肺功能检查和胸部影像的结节病患者,进入研究时中位年龄50岁(范围25-78岁),随访至少8年。
研究设计与关键结果
- 研究类型为队列研究,纳入452例患者,中位年龄50岁(范围25-78岁),随访至少8年。
- 随访期间42例死亡,其中38例(8.4%)死于结节病相关呼吸衰竭,4例死于非结节病原因。
- 结节病总体死亡率5年为3.9%,10年为9.0%。
- 单因素分析显示黑人种族、胸部X线4期、HRCT纤维化>20%、肺动脉高压、GAP指数及Walsh模型与死亡率升高相关。
- 多因素Cox回归显示仅年龄、HRCT纤维化范围和肺动脉高压为独立预测因素。
证据类型、等级与局限
- 证据类型:队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对结节病患者评估预后时,可关注年龄、HRCT纤维化范围及肺动脉高压;这三项为独立预测因素。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: The goal of this study was to assess the prognostic strength of factors in predicting respiratory death in a large cohort of patients with sarcoidosis with at least 8 years' follow-up.
METHODS: Data were collected on age, sex, self-declared race, time of death, spirometry findings, diffusing capacity for carbon monoxide, chest radiograph stage, extent of fibrosis on high-resolution CT (HRCT) scanning, and presence of precapillary pulmonary hypertension (PH). The Gender-Age-Physiology (GAP) index and Walsh model criteria for high vs low risk were calculated.
RESULTS: A total of 452 patients were identified who had complete pulmonary function testing and chest imaging. The median age at time of entry into the study was 50 years (range, 25-78 years). PH was confirmed by right heart catheterization in 29 (6.4%). Of 452 patients, 42 died during the time of the study, including 38 (8.4%) who died of sarcoidosis-associated respiratory failure and 4 who died of non-sarcoidosis causes. The overall mortality from sarcoidosis was 3.9% and 9.0% at 5 and 10 years, respectively. Alive patients were significantly younger than patients who died from sarcoidosis. Increased mortality was seen for black patients, stage 4 chest radiographs, > 20% fibrosis on HRCT scanning, or PH. The two composite scores (GAP and the Walsh model) were predictive of increased mortality according to univariate analysis. Using the Cox proportional hazards regression model, only age, extent of fibrosis on HRCT scanning, and PH were independent predictors of mortality.
CONCLUSIONS: Although most patients with sarcoidosis do well, increased mortality was seen in those patients who were older, had extensive fibrosis on HRCT scanning, or who had PH.
参考来源
- Kirkil G, Lower EE, Baughman RP, et al. Predictors of Mortality in Pulmonary Sarcoidosis. Chest. 2017. PMID: 28728933. doi:10.1016/j.chest.2017.07.008
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。